DK vs NBIX · rev $2.37B vs P/E 45, rev $2.36B
Delek US Energy Inc (DK) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Delek US Energy Inc (DK) is a oil & gas refining & marketing company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DK revenue for 2024-12-31 was $2.37B. Net income was -$402.1M. Revenue was down 22.0% from 2024-09-30 to 2024-12-31. DK currently screens at market cap $2.96B.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DK currently screens at market cap $2.96B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DK and NBIX stock pages for the full models.
Not investment advice.